Glaser Daniel S 4

What Happened Daniel S. Glaser, a director of MetLife, Inc. (MET), was credited with 7 shares on 2026-06-09 under an award/other acquisition (code A) at $85.57 per share, for a total value of approximately $599. The filing indicates these are imputed reinvestments of dividends on deferred shares under MetLife’s Deferred Compensation Plan for Non-Management Directors and are held in a GRAT (grantor retained annuity trust).

Key Details

• Transaction date: 2026-06-09; Form 4 filed 2026-06-11 (appears timely).
• Transaction type/code: A — Award/other acquisition (dividend reinvestment).
• Shares acquired: 7 at $85.57 each; total ≈ $599.
• Shares owned after transaction: not reported in the provided excerpt.
• Footnotes: F1 — imputed reinvestment of dividends on deferred shares under the director deferred compensation plan; F2 — shares are held in a GRAT.
• Remarks: Deferred shares rounded to the nearest whole number.

Context This was not an open‑market purchase but a routine crediting of deferred shares via dividend reinvestment and placement in a trust (GRAT). Such director deferred‑compensation and dividend‑reinvestment entries are common and do not necessarily indicate a change in the director’s view of the stock.